Aniara Grant

Aniara Diagnostica’s Coagulation Research Grant provides $10,000 for established investigators (eg – faculty at an academic institution) and for students/trainees to do innovative coagulation / hematology research. Deadline for receipt of application is November 1, 2026.

The Aniara Research Panel awards two yearly $10,000 grant – 1 for Aniara’s territory (North America & Scandinavia) and 1 global – for specialized in hematology and coagulation research. All proposed projects must in the coagulation / hematology scientific field.

This Grant Program does not pay educational tuition, nor does it offer scholarships of fellowships of any kind.

Applicants are expected to have advanced degress (Ph.D. or equivalent) and be associated with an educational organization or institution. Independent researchers or those pursuing a Ph.D.-level degree may apply, but awards to non-Ph.D. applicants are rare. As a general rule, all applicants are expected to have published a minimum of three articles in peer-reviewed scientific journals.

Aniara Diagnostica will award two yearly $10,000 grants – one $10,000 grant recipient for Aniara’s territory and 1 $10,000 grant recipient global per year.

Aniara Coagulation Research Grants may not be used for indirect costs, overhead, and other expenses not directly related to the project. Fringe benefits are also excluded, as are salaries.

Funds may not be used for travel to scientific / professional meetings or conferences, legal actions, land acquisition, endowments, construction of permanent field stations, or publishing research results.

Thank you for applying.

Grant Application

Szumam Liu,
PhD

Szumam Liu is a Research Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center. After earning a B.S. in Biotechnology in 2009, she received her Ph.D. in Biomedical Sciences and Engineering in 2017. She furthered her expertise through postdoctoral fellowships at the University of Alabama at Birmingham and the University of Kansas Medical Center, completing her advanced training in 2024.

Her research activity is primarily focused on the molecular biology of gene regulation, hemostasis, and thrombosis. She specializes in epigenetic mechanisms—specifically protein arginine methylation—and their roles in thrombotic and inflammatory diseases, such as Thrombotic Thrombocytopenic Purpura (TTP). Her current work identifies novel methylation sites on ADAMTS13 to develop new therapeutic strategies.

She has presented her work at several international congresses, including the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH). Her research has been recognized with numerous honors, including the ISTH Early Career Travel Award and the ASH Abstract Achievement Award. Additionally, she serves as the Principal Investigator for research focused on ADAMTS13 mutations. Finally, she is actively involved in the scientific community as an editor and reviewer for Frontiers in Immunology and serves as a judge for academic research forums

Harriet Allan

Dr Harriet Allan is a British Heart Foundation Research Fellow based at the Blizard Institute, Queen Mary University of London. Her research focuses on investigating mitochondrial dynamics in platelets and megakaryocytes, with a particular interest on the role of platelet mitochondrial transfer in modulating the function of circulating cells.

2025 - Szumam Liu
2023 - Nicola Pozzi, Ph.D
2021 - Jessical Cardenas, PhD
2020 - Saravanan Subramaniam, PhD
2017 - Christina M . Laukaitis, MD, PhD and Dr. Rohith Jesudas, MD
2015 - Randal Westrick, PhD
2013 - Luigi Brunetti, PharmD, MPH, BCPS, CGP
2012 - Dr. Chad M. Paton, PhD
2010 - Leonardo R. Brandao, MD
2009 - Dr. Mirta Schattner PhD
2008 - Dr. Graciela Krikun, PhD
2007 - Dr. Margaret Prechel, PhD
2006 - Dr. A. Valance Washington, PhD

Dr. Dorothy Adcock
Medical Director / Laboratory Director Colorado
Coagulation Consultants, Inc. dba Esoterix Coagulation, Denver, Colorado

Dr. Kenneth A. Bauer
Professor of Medicine, Harvard Medical School. His hospital positions included Chief, Hematology Section, VA Boston Healthcare System, and Director, Thrombosis Clinical Research, Beth Israel Deaconess Medical Center.

Dr. Charles S. Eby
Associate Director of Educational Programs, Division of Laboratory Medicine at Washington
University Saint Louis, Member of Barnes – Jewish Hospital Credentialing and Health Information Management Committees

Dr. Andreas Hillarp
Position as hospital chemist at the Department of Clinical Chemistry, University Hospital, Malmo, Sweden

Dr. Mervyn A. Sahud, M.D., A.B.I. M.-Hem.
Medical Director Coagulation Department Quest Diagnostics Nichols Institute

Dr. Sam Schulman
Associate professor in Internal Medicine at Karolinska Institute and since September 2004 also professor in medicine at McMaster University.

Agneta Siegbahn, MD, Ph.D
Professor in Clinical Coagulation Science Department of Medical Sciences, Clinical Chemistry Akademiska Hospital, Uppsala, Sweden.

Jogin R. Wu, Ph.D.
Associate Clincial Professor of Pathology, Duke University Medical Center. Associate Director, Clinical Coagulation Laboratory, Duke University Health System.